Patanjali Ayurved Ltd., on Wednesday, issued a statement saying that all documents related to the Covid-19 clinical trial have been shared with the AYUSH Ministry and that there exists “no difference of opinions between the ministry and Patanjali.
In the statement, Patanjali said that Covid-19 patients group that received its medicines, showed 67% recovery in 3 days and 100% recovery in 7 days of treatment. “That is, all 45 patients became Covid-19 negative,” the statement read.
Patanjali claims that the ministry has categorically agreed that “Patanjali Research Foundation has appropriately worked on Covid-19 management”.
As per the statement, Patanjali says it is allowed by the Ministry to “manufacture and distribute its Divya Coronil Tablets, Divya SwasarVati and Divya AnuTaila across India”.
This comes a day after Acharya Balkrishna, the chief executive officer of Patanjali clarified that the company never claimed that its newly-tested medicines would treat Covid-19.
“We cited Coronil as ayurvedic medicine for immunity boosting, fever, cough and allergic problems,” Balkrishna said, adding, “Only results of clinical trial based curing of positive patients were claimed by us”.
Source: Read Full Article